399 related articles for article (PubMed ID: 9677321)
21. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer.
Shapiro AB; Corder AB; Ling V
Eur J Biochem; 1997 Nov; 250(1):115-21. PubMed ID: 9431998
[TBL] [Abstract][Full Text] [Related]
22. Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein.
Shapiro AB; Ling V
Eur J Biochem; 1998 May; 254(1):181-8. PubMed ID: 9652412
[TBL] [Abstract][Full Text] [Related]
23. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
24. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
25. Understanding polyspecificity within the substrate-binding cavity of the human multidrug resistance P-glycoprotein.
Martinez L; Arnaud O; Henin E; Tao H; Chaptal V; Doshi R; Andrieu T; Dussurgey S; Tod M; Di Pietro A; Zhang Q; Chang G; Falson P
FEBS J; 2014 Feb; 281(3):673-82. PubMed ID: 24219411
[TBL] [Abstract][Full Text] [Related]
26. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism.
Bergman PJ; Gravitt KR; Ward NE; Beltran P; Gupta KP; O'Brian CA
Invest New Drugs; 1997; 15(4):311-8. PubMed ID: 9547673
[TBL] [Abstract][Full Text] [Related]
27. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
28. Communication between multiple drug binding sites on P-glycoprotein.
Martin C; Berridge G; Higgins CF; Mistry P; Charlton P; Callaghan R
Mol Pharmacol; 2000 Sep; 58(3):624-32. PubMed ID: 10953057
[TBL] [Abstract][Full Text] [Related]
29. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
30. Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Biochim Biophys Acta; 2000 Aug; 1481(1):63-74. PubMed ID: 10962093
[TBL] [Abstract][Full Text] [Related]
31. Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein.
Eytan GD; Borgnia MJ; Regev R; Assaraf YG
J Biol Chem; 1994 Oct; 269(42):26058-65. PubMed ID: 7523400
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of (S)-valine thiazole-derived cyclic and noncyclic peptidomimetic oligomers as modulators of human P-glycoprotein (ABCB1).
Singh S; Prasad NR; Kapoor K; Chufan EE; Patel BA; Ambudkar SV; Talele TT
Chembiochem; 2014 Jan; 15(1):157-69. PubMed ID: 24288265
[TBL] [Abstract][Full Text] [Related]
33. Characterization and functional reconstitution of the multidrug transporter.
Sharom FJ
J Bioenerg Biomembr; 1995 Feb; 27(1):15-22. PubMed ID: 7629046
[TBL] [Abstract][Full Text] [Related]
34. The role of passive transbilayer drug movement in multidrug resistance and its modulation.
Eytan GD; Regev R; Oren G; Assaraf YG
J Biol Chem; 1996 May; 271(22):12897-902. PubMed ID: 8662680
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.
Litman T; Zeuthen T; Skovsgaard T; Stein WD
Biochim Biophys Acta; 1997 Aug; 1361(2):159-68. PubMed ID: 9300797
[TBL] [Abstract][Full Text] [Related]
36. New insights into the P-glycoprotein-mediated effluxes of rhodamines.
Loetchutinat C; Saengkhae C; Marbeuf-Gueye C; Garnier-Suillerot A
Eur J Biochem; 2003 Feb; 270(3):476-85. PubMed ID: 12542697
[TBL] [Abstract][Full Text] [Related]
37. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.
Doige CA; Sharom FJ
Biochim Biophys Acta; 1992 Aug; 1109(2):161-71. PubMed ID: 1355667
[TBL] [Abstract][Full Text] [Related]
38. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study.
Lizard G; Roignot P; Maynadie M; Lizard-Nacol S; Poupon MF; Bordes M
Cancer Detect Prev; 1995; 19(6):527-34. PubMed ID: 8925522
[TBL] [Abstract][Full Text] [Related]
40. Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agents.
Quesada AR; Barbacid MM; Mira E; Aracil M; Márquez G
Cancer Lett; 1996 Jan; 99(1):109-14. PubMed ID: 8564921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
